Tzu-Chen Yen ,M.D.,Ph.D.
Intitution:
Department: Department of Nuclear Medicine
Mail Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-328-1200 ext.2673 Fax:+886 3 2110052
E-mail: yen1110@adm.cgmh.org.tw
Focus of Interest:
1991/06 Ph.D. Institute of Clinical Medicine, National Yang-Ming University, Taipei,
Fulltime Employment:
◎ 2012/6~Present Director, Academia–Industry Collaboration Office, Chang Gung Memorial Hospital
◎ 2011/10~Present Director, Planning Center, Chang Gung Memorial Hospital
◎ 2002/7~Present Professor and Director, Center for Advanced Molecular Imaging and Translation, Chang Gung Medical Foundation
◎ 1997/2~Present Associate Professor, Department of Medicine, School of Medicine, Chang Gung University
Selected Publications:
Full Publication List
Honor and Awards:
- 2012/05 國立陽明大學學術類傑出校友獎
- 2012/12 Certiificate of Golden Award of 2012 National Biotechnology and Medical Care Quality Award
Board Certification / Professional Affiliations:
(1) 中華民國核醫學學會委員 Society of Nuclear Medicine, Taiwan(R.O.C)
(2) 行政院原子能委員會游離輻射安全諮詢會委員
(3) 行政院原子能委員會衛生福利部食品藥物管理署醫療器材諮議委員
(4) 財團法人醫藥品查驗中心(Center For Drug Evaluation) 業務指導顧問
Ongoing Projects:
Intitution:
- Director, Planning Center, Chang Gung Memorial Hospital
- Director, Center for Academia and Industrial Collaboration, Chang Gung Memorial Hospital
- Professor and Director, Center for Advanced Molecular Imaging and Translation , Chang Gung Memorial Hospital-Linkou
- Professor, School of Medicine, Chang Gung University
Department: Department of Nuclear Medicine
Mail Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-328-1200 ext.2673 Fax:+886 3 2110052
E-mail: yen1110@adm.cgmh.org.tw
Focus of Interest:
- Medical Imaging
1991/06 Ph.D. Institute of Clinical Medicine, National Yang-Ming University, Taipei,
Fulltime Employment:
◎ 2012/6~Present Director, Academia–Industry Collaboration Office, Chang Gung Memorial Hospital
◎ 2011/10~Present Director, Planning Center, Chang Gung Memorial Hospital
◎ 2002/7~Present Professor and Director, Center for Advanced Molecular Imaging and Translation, Chang Gung Medical Foundation
◎ 1997/2~Present Associate Professor, Department of Medicine, School of Medicine, Chang Gung University
Selected Publications:
- Peng CH, Jiang YZ, Tai AS, Liu CB, Peng SC, Liao CT, Yen TC*, Hsieh WP. Causal inference of gene regulation with subnetwork assembly from genetical genomics data. Nucleic Acids Res. 2014;42:2803-19. correspondence
- Hsiao IT, Huang CC, Hsieh CJ, Wey SP, Kung MP, Yen TC*, Lin KJ. Perfusion-like template and standardized normalization-based brain image analysis using (18)F-florbetapir (AV-45/Amyvid) PET. Eur J Nucl Med Mol Imaging. 2013;40:908-20. correspondence
- Lu PL, Chen YC, Ou TW, Chen HH, Tsai HC, Wen CJ, Lo CL, Wey SP, Lin KJ, Yen TC*, Hsiue GH. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials. 2011;32:2213-21. co-correspondence
- Liu HL, Wai YY, Hsu PH, Lyu LA, Wu JS, Shen CR, Chen JC, Yen TC *, Wang JJ *. In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: amagnetic resonance imaging study. J Cerebr Blood F Met. 2010;30:177-86. (SCI=5.398) correspondence
- Lin KJ*, Weng YH*, Wey SP, Hsiao IT, Lu CS, Skovronsky D, Chang HP, Kung MP, Yen TC*. Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133) - a Novel vesicular monoamine transporter 2 imaging agent. J Nucl Med. 2010;51:1480-5. correspondence
Full Publication List
Honor and Awards:
- 2012/05 國立陽明大學學術類傑出校友獎
- 2012/12 Certiificate of Golden Award of 2012 National Biotechnology and Medical Care Quality Award
Board Certification / Professional Affiliations:
(1) 中華民國核醫學學會委員 Society of Nuclear Medicine, Taiwan(R.O.C)
(2) 行政院原子能委員會游離輻射安全諮詢會委員
(3) 行政院原子能委員會衛生福利部食品藥物管理署醫療器材諮議委員
(4) 財團法人醫藥品查驗中心(Center For Drug Evaluation) 業務指導顧問
Ongoing Projects:
- Establishing a GLP-compliant and certified laboratory for preclinical imaging studies.
- Role of FDG-PET for Early Detection of Residual/Relapse Disease in Oral Cavity Cancer Patients at the Interval of after Radical Surgery and before Adjuvant Therapy.
- Automatic detection and characterization of residual masses in patients with lymphomas through fusion of whole-body diffusion-weighted MRI on 3T and 18F-fluorodeoxyglucose.
- Phase II study of [18F] RGD-K5 in Head and Neck Cancer Patients.
- Phase II study of [18F]AV-45 PET amyloid binding imaging for patients with mild cognitive impartment, Alzheimer’s disease and healthy volunteers.